Neutral
●
Seeking Alpha
●
vor 5 Monaten
HCA Healthcare has delivered robust earnings, aggressive buybacks, and margin expansion, driving shares up over 40% in the past year. Q4 results and 2026 guidance were strong, but margin benefits may be peaking and policy headwinds from Medicaid and ACA changes loom. HCA's valuation is now full at ~16x earnings and a 6% free cash flow yield, with future margin compression risk not fully discoun...